You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 23, 2024

CLINICAL TRIALS PROFILE FOR DANICOPAN


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for DANICOPAN

Trial ID Title Status Sponsor Phase Start Date Summary
NCT03053102 ↗ Study of Danicopan in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Completed Achillion, a wholly owned subsidiary of Alexion Phase 2 2017-03-31 The purpose of this study was to determine the safety and efficacy of ACH-0144471 (also known as danicopan and ALXN2040) in currently untreated participants with PNH.
NCT03053102 ↗ Study of Danicopan in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Completed Achillion Pharmaceuticals Phase 2 2017-03-31 The purpose of this study was to determine the safety and efficacy of ACH-0144471 (also known as danicopan and ALXN2040) in currently untreated participants with PNH.
NCT03053102 ↗ Study of Danicopan in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Completed Alexion Pharmaceuticals Phase 2 2017-03-31 The purpose of this study was to determine the safety and efficacy of ACH-0144471 (also known as danicopan and ALXN2040) in currently untreated participants with PNH.
NCT03108274 ↗ A Drug Interaction Study Between Danicopan and Midazolam, Fexofenadine, and Mycophenolate Mofetil in Healthy Participants Completed Achillion, a wholly owned subsidiary of Alexion Phase 1 2017-04-18 The purpose of this study was to determine the potential drug interaction between danicopan (ACH-0144471) and midazolam, fexofenadine, and mycophenolate mofetil. This was a 3-part study, with each part being an open-label, fixed-sequence, 2-treatment study in healthy adult participants.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for DANICOPAN

Condition Name

Condition Name for DANICOPAN
Intervention Trials
Healthy 13
C3 Glomerulonephritis 3
C3 Glomerulopathy 3
Dense Deposit Disease 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for DANICOPAN
Intervention Trials
Hemoglobinuria, Paroxysmal 5
Hemoglobinuria 5
Glomerulonephritis 3
Glomerulonephritis, Membranoproliferative 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for DANICOPAN

Trials by Country

Trials by Country for DANICOPAN
Location Trials
United States 47
Italy 9
United Kingdom 8
New Zealand 7
France 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for DANICOPAN
Location Trials
Arizona 6
Florida 3
Ohio 3
California 3
Texas 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for DANICOPAN

Clinical Trial Phase

Clinical Trial Phase for DANICOPAN
Clinical Trial Phase Trials
Phase 3 2
Phase 2 8
Phase 1 14
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for DANICOPAN
Clinical Trial Phase Trials
Completed 17
Recruiting 3
Not yet recruiting 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for DANICOPAN

Sponsor Name

Sponsor Name for DANICOPAN
Sponsor Trials
Alexion Pharmaceuticals 23
Achillion, a wholly owned subsidiary of Alexion 14
Achillion Pharmaceuticals 7
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for DANICOPAN
Sponsor Trials
Industry 47
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.